XADAGO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Estonia, Finland, France, Germany, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Spain, Turkey, UK.

Active ingredients

The drug XADAGO contains one active pharmaceutical ingredient (API):

1	Safinamide UNII YS90V3DTX0 - SAFINAMIDE MESYLATE
	Safinamide acts through both dopaminergic and non-dopaminergic mechanisms of action. Safinamide is a highly selective and reversible MAO-B inhibitor causing an increase in extracellular levels of dopamine in the striatum. Safinamide is indicated for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as addon therapy to a stable dose of levodopa (L-dopa).
	Read more about Safinamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
XADAGO Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BD03		N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BD Monoamine oxidase B inhibitors
Discover more medicines within N04BD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11656L, 11666B
BR	Câmara de Regulação do Mercado de Medicamentos	533819020009002, 533819020009102, 533819020009202, 533819020009302, 533819020009402
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	10937995, 10938026, 10938032, 10938049
EE	Ravimiamet	1677810, 1677821, 1677832, 1677843, 1677854, 1677865, 1677876, 1677887, 1677898, 1677900
ES	Centro de información online de medicamentos de la AEMPS	114984003, 114984003IP, 114984008, 114984008IP
FI	Lääkealan turvallisuus- ja kehittämiskeskus	047943, 106219, 542507, 545736
FR	Base de données publique des médicaments	61882445, 66932795
GB	Medicines & Healthcare Products Regulatory Agency	325049, 325052
IL	מִשְׂרַד הַבְּרִיאוּת	8885, 8886
IT	Agenzia del Farmaco	043906015, 043906027, 043906039, 043906041, 043906054, 043906066, 043906078, 043906080, 043906092, 043906104
LT	Valstybinė vaistų kontrolės tarnyba	1075828, 1075829, 1075830, 1075831, 1075832, 1075833, 1075834, 1075835, 1075836, 1075837
NL	Z-Index G-Standaard, PRK	130745, 130753
PL	Rejestru Produktów Leczniczych	100338977, 100338983
TR	İlaç ve Tıbbi Cihaz Kurumu	8699769090227, 8699769090234
US	FDA, National Drug Code	27505-110, 27505-111